| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Corrigendum to “Clinical trial designs for evaluating and exploiting cancer evolution” [Cancer Treat. Rev. 118 (2023) 101583]
|
Ingles Garces, Alvaro H.
|
|
|
119 |
C |
p.
|
artikel
|
| 2 |
Corrigendum to “Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review” [Cancer Treat. Rev. 114 (2023) 102511]
|
Miglietta, F.
|
|
|
119 |
C |
p.
|
artikel
|
| 3 |
Current indications and future perspectives for antibody-drug conjugates in brain metastases of breast cancer
|
Epaillard, N.
|
|
|
119 |
C |
p.
|
artikel
|
| 4 |
Editorial Board
|
|
|
|
119 |
C |
p.
|
artikel
|
| 5 |
Immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: A systematic review
|
Attili, Ilaria
|
|
|
119 |
C |
p.
|
artikel
|
| 6 |
Managing cisplatin-ineligible patients with resected, high-risk, locally advanced squamous cell carcinoma of the head and neck: Is there a standard of care?
|
Haddad, Robert I.
|
|
|
119 |
C |
p.
|
artikel
|
| 7 |
Review: Targeting EZH2 in neuroblastoma
|
Gao, Jinhui
|
|
|
119 |
C |
p.
|
artikel
|
| 8 |
Risk of thromboembolic events in patients with metastatic solid tumors treated with PARP inhibitors: A systematic review and meta-analysis of phase 3 randomized controlled trials
|
Castellano, Grazia
|
|
|
119 |
C |
p.
|
artikel
|
| 9 |
Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis
|
Becherini, Carlotta
|
|
|
119 |
C |
p.
|
artikel
|
| 10 |
Strategies for improving detection of circulating tumor DNA using next generation sequencing
|
Tébar-Martínez, Roberto
|
|
|
119 |
C |
p.
|
artikel
|
| 11 |
The immunogram of inflammatory breast cancer
|
Valenza, Carmine
|
|
|
119 |
C |
p.
|
artikel
|
| 12 |
Uveal melanoma: In the era of new treatments
|
Wespiser, M.
|
|
|
119 |
C |
p.
|
artikel
|
Tijdschrift beschrijving